FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:1110-1111 October 3, 2002 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

The use of susceptibility testing to identify appropriate antimicrobial agents has long been an important element of the practice of infectious-disease medicine. In most clinical settings, the finding that a strain of bacteria is susceptible to a specific antibiotic is a reliable indicator of the effectiveness of that drug. An exception is the treatment of pulmonary infection in patients with cystic fibrosis. Once chronic Pseudomonas aeruginosa infection is established in the lungs of these patients, the bacteria are rarely, if ever, eradicated despite treatment with combinations of antimicrobial agents with demonstrated potency in vitro. Even direct administration of aerosolized antibiotics . . . [Full Text of this Article]

This article has been cited by other articles:

• Wolcott, R. D., Ehrlich, G. D. (2008). Biofilms and Chronic Infections. JAMA 299: 2682-2684 [Full Text]  
• Besier, S., Zander, J., Kahl, B. C., Kraiczy, P., Brade, V., Wichelhaus, T. A. (2008). The Thymidine-Dependent Small-Colony-Variant Phenotype Is Associated with Hypermutability and Antibiotic Resistance in Clinical Staphylococcus aureus Isolates. Antimicrob. Agents Chemother. 52: 2183-2189 [Abstract] [Full Text]  
• Kremer, T. M., Zwerdling, R. G., Michelson, P. H., O'Sullivan, B. P. (2008). Intensive Care Management of the Patient With Cystic Fibrosis. J Intensive Care Med 23: 159-177 [Abstract]  
• Schaber, J. A., Hammond, A., Carty, N. L., Williams, S. C., Colmer-Hamood, J. A., Burrowes, B. H., Dhevan, V., Griswold, J. A., Hamood, A. N. (2007). Diversity of biofilms produced by quorum-sensing-deficient clinical isolates of Pseudomonas aeruginosa. J Med Microbiol 56: 738-748 [Abstract] [Full Text]  
• Starner, T. D., McCray, P. B. Jr. (2005). Pathogenesis of Early Lung Disease in Cystic Fibrosis: A Window of Opportunity To Eradicate Bacteria. ANN INTERN MED 143: 816-822 [Full Text]  
• Garcia-Medina, R., Dunne, W. M., Singh, P. K., Brody, S. L. (2005). Pseudomonas aeruginosa Acquires Biofilm-Like Properties within Airway Epithelial Cells. Infect. Immun. 73: 8298-8305 [Abstract] [Full Text]  
• Moskowitz, S. M., Foster, J. M., Emerson, J. C., Gibson, R. L., Burns, J. L. (2005). Use of Pseudomonas biofilm susceptibilities to assign simulated antibiotic regimens for cystic fibrosis airway infection. J Antimicrob Chemother 56: 879-886 [Abstract] [Full Text]  
• Wang, E. W., Jung, J. Y., Pashia, M. E., Nason, R., Scholnick, S., Chole, R. A. (2005). Otopathogenic Pseudomonas aeruginosa Strains as Competent Biofilm Formers. Arch Otolaryngol Head Neck Surg 131: 983-989 [Abstract] [Full Text]  
• Sadikot, R. T., Blackwell, T. S., Christman, J. W., Prince, A. S. (2005). Pathogen-Host Interactions in Pseudomonas aeruginosa Pneumonia. Am. J. Respir. Crit. Care Med. 171: 1209-1223 [Abstract] [Full Text]  
• Greiner, L. L., Edwards, J. L., Shao, J., Rabinak, C., Entz, D., Apicella, M. A. (2005). Biofilm Formation by Neisseria gonorrhoeae. Infect. Immun. 73: 1964-1970 [Abstract] [Full Text]  
• Raffa, R. B., Iannuzzo, J. R., Levine, D. R., Saeid, K. K., Schwartz, R. C., Sucic, N. T., Terleckyj, O. D., Young, J. M. (2005). Bacterial Communication ("Quorum Sensing") via Ligands and Receptors: A Novel Pharmacologic Target for the Design of Antibiotic Drugs. J. Pharmacol. Exp. Ther. 312: 417-423 [Abstract] [Full Text]  
• Edwards, E.A., Narang, I., Li, A., Hansell, D.M., Rosenthal, M., Bush, A. (2004). HRCT lung abnormalities are not a surrogate for exercise limitation in bronchiectasis. Eur Respir J 24: 538-544 [Abstract] [Full Text]  
• Moskowitz, S. M., Foster, J. M., Emerson, J., Burns, J. L. (2004). Clinically Feasible Biofilm Susceptibility Assay for Isolates of Pseudomonas aeruginosa from Patients with Cystic Fibrosis. J. Clin. Microbiol. 42: 1915-1922 [Abstract] [Full Text]  
• Gibson, R. L., Burns, J. L., Ramsey, B. W. (2003). Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis. Am. J. Respir. Crit. Care Med. 168: 918-951 [Abstract] [Full Text]  
• Conley, J., Olson, M. E., Cook, L. S., Ceri, H., Phan, V., Davies, H. D. (2003). Biofilm Formation by Group A Streptococci: Is There a Relationship with Treatment Failure?. J. Clin. Microbiol. 41: 4043-4048 [Abstract] [Full Text]